S. Korsatko

发表

Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during ‘real‐life’ glucose excursions

M. Ellmerer, J. Plank, J. Mader, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing

L. Schaupp, T. Heise, S. Korsatko, 2013, Biomedizinische Technik. Biomedical engineering.

Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

S. Heller, T. Pieber, A. Holst, 2018, Diabetes, obesity & metabolism.

Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2

R. Krause, C. Sebesta, V. Kallab, 2021, medRxiv.

The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.

T. Pieber, H. Olschewski, J. Råstam, 2010, British journal of clinical pharmacology.

Posters_Tuesday 13 October 2009

R. Hovorka, M. Nijsten, M. Vogelzang, 2009, Intensive Care Medicine.

Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.

T. Pieber, M. Bodenlenz, W. Regittnig, 2013, Diabetes technology & therapeutics.

Novel catheters for in vivo research and pharmaceutical trials providing direct access to extracellular space of target tissues

T. Pieber, L. Schaupp, C. Magnes, 2010 .

Steady state is reached within 2–3 days of once‐daily administration of degludec, a basal insulin with an ultralong duration of action

T. Heise, L. Nosek, S. Segel, 2016, Journal of diabetes.

A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes

J. Mader, A. Wutte, G. Bock, 2013, Diabetes, obesity & metabolism.

Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling.

T. Pieber, L. Schaupp, C. Magnes, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood.

M. Ellmerer, N. D. de Rooij, T. Pieber, 2012, Biomicrofluidics.

Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients.

Roman Hovorka, Gerd Köhler, Johannes Plank, 2010, Diabetes technology & therapeutics.

Enhanced Absorption of Insulin Aspart as the Result of a Dispersed Injection Strategy Tested in a Randomized Trial in Type 1 Diabetic Patients

T. Pieber, F. Sinner, J. Mader, 2013, Diabetes Care.

Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients.

M. Ellmerer, J. Plank, T. Pieber, 2010, Cytokine.

A prolonged run-in period of standard subcutaneous microdialysis ameliorates quality of interstitial glucose signal in patients after major cardiac surgery

M. Ellmerer, J. Plank, T. Pieber, 2018, Scientific Reports.

Pharmacodynamics of the long‐acting insulin analogues detemir and glargine following single‐doses and under steady‐state conditions in patients with type 1 diabetes

A. Wutte, J. Mader, S. Korsatko, 2014, Diabetes, obesity & metabolism.

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

S. Heller, T. Pieber, H. Haahr, 2013, Diabetologia.

Clinical applicability of dOFM devices for dermal sampling

L. Schaupp, C. Magnes, F. Sinner, 2013, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Glucose Levels at the Site of Subcutaneous Insulin Administration and Their Relationship to Plasma Levels

M. Ellmerer, T. Pieber, L. Schaupp, 2010, Diabetes Care.

Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes

M. Ellmerer, T. Pieber, L. Schaupp, 2009, Diabetes Care.

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM

T. Pieber, C. Magnes, J. Mader, 2018, The Journal of clinical endocrinology and metabolism.

A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec

T. Pieber, J. Mader, H. Thomsen, 2013, Clinical Drug Investigation.

The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.

T. Pieber, P. Clauson, P. Wollmer, 2008, British journal of clinical pharmacology.

Hypoglycaemic coma due to falsely high point-of-care glucose measurements in an ICU-patient with peritoneal dialysis: a critical incidence report

Lukas Schaupp, Johannes Plank, Julia K. Mader, 2009, Intensive Care Medicine.